Response to: "Prognostic relevance of epilepsy at presentation in lower-grade gliomas".

Berendsen, Sharon; Snijders, Tom J.; Robe, Pierre

doi:10.1093/neuonc/now161

Request a copy

Article (Scientific journals)

Response to: "Prognostic relevance of epilepsy at presentation in lower-grade gliomas".

Berendsen, Sharon; Snijders, Tom J.; Robe, Pierre

2016 • In Neuro-Oncology, 18 (9), p. 1327-8

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/206593

DOI
10.1093/neuonc/now161

PubMed
27563106

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Response to 2016 Robe.pdf

Publisher postprint (118.47 kB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Disciplines :

Genetics & genetic processes

Author, co-author :

Berendsen, Sharon

Snijders, Tom J.

Robe, Pierre ; Université de Liège > Département des sciences biomédicales et précliniques > Département des sciences biomédicales et précliniques

Language :

English

Title :

Response to: "Prognostic relevance of epilepsy at presentation in lower-grade gliomas".

Publication date :

2016

Journal title :

Neuro-Oncology

ISSN :

1522-8517

eISSN :

1523-5866

Publisher :

Oxford University Press

Volume :

Issue :

Pages :

1327-8

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 31 January 2017

Statistics

Number of views

40 (0 by ULiège)

Number of downloads

0 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Berendsen S, Varkila M, Kroonen J, et al. Prognostic relevance of epilepsy at presentation in glioblastoma patients. Neuro Oncol. 2015;Sep 29. pii: nov238. [Epub ahead of print].
Gorlia T, Wu W, Wang M, et al. New validated prognostic models and prognostic calculators in patients with low-grade glio-mas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trials. Neuro Oncol. 2013;15(11):1568-1579.
Eckel-Passow JE, Lachance DH, Molinaro AM, et al. Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors. N Engl J Med. 2015;372(26):2499-508.